Skip to content
More than 500 DIO mice ready to be enrolled in studies every month

Explore our extensive capabilities
in the obesity space

Gubra has 15+ years of experience with DIO animals, successfully profiling numerous anti-obesity drug candidates. Our capabilities spam from chronic efficacy studies focused on body weight, composition and specific muscle assessments, real-time food intake, energy expenditure and locomotr activity, 3D imaging analysis of c-Fos activation.

Explore our data

Download the Latest Posters

Download the posters and explore how we can help accelerate your drug development with a solid portfolio of preclinical obesity models and latest technology.

Standard Obesity & Diabetes Study Outline

We are experts in bridging preclinical and clinical development.

MARCO TOZZI Senior Scientist

Marco has a background in in vivo physiology, focused on preclinical obesity and diabetes research. With his experience and expertise, he can provide valuable scientific guidance in the design and execution of obesity/diabetes studies, as well as in profiling anti-obesity/diabetes drugs.

Have any questions?

Contact us


Hørsholm Kongevej 11B
2970 Hørsholm

+45 3152 ­2650

Back To Top